Skip directly to Accessibility Notice

EMRIX
Emerging Markets Fund - Class I

Market Updates*

  • Going into 2021, we believe vaccination success on top of a benign cocktail of low rates, low inflation and ample liquidity may create a favorable atmosphere for emerging markets.
  • At a minimum, we believe style and emphasis change in China/U.S. relations will help headline risk for the asset class.
  • Acceleration of digital trends should maintain momentum, but performance may broaden out into a wider landscape of smaller companies and countries, creating potential compelling stock specific opportunities for the true all-cap VanEck Emerging Markets Equity Strategy.
  • As COVID-19 unfolded, significant market turbulence disproportionately affected small- and mid-cap stocks in emerging markets, as is often the case in times of heightened risk. As markets normalize, we believe it is reasonable to expect relative outperformance from these smaller stocks.

Learn More | The Disruption of Fintech Across Emerging Markets

Market Updates*

  • Going into 2021, we believe vaccination success on top of a benign cocktail of low rates, low inflation and ample liquidity may create a favorable atmosphere for emerging markets.
  • At a minimum, we believe style and emphasis change in China/U.S. relations will help headline risk for the asset class.
  • Acceleration of digital trends should maintain momentum, but performance may broaden out into a wider landscape of smaller companies and countries, creating potential compelling stock specific opportunities for the true all-cap VanEck Emerging Markets Equity Strategy.
  • As COVID-19 unfolded, significant market turbulence disproportionately affected small- and mid-cap stocks in emerging markets, as is often the case in times of heightened risk. As markets normalize, we believe it is reasonable to expect relative outperformance from these smaller stocks.

Learn More | The Disruption of Fintech Across Emerging Markets

Click here to read the EME White paper - The Disruption of Fintech Across Emerging Markets
Click here to read the EME Whitepaper - The Disruption of Fintech Across Emerging Markets

Daily Price as of 03/05/21

NAV DAILY CHANGE
$23.20 $0.13 / +0.6%

Class I Details: EMRIX

INCEPTION DATE GROSS/NET EXPENSES1
1.16%/1.00%

EM Equity

VanEck's Emerging Markets Equity Investment Team seeks secular growth trends, such as domestic consumption, that contribute materially to the economic health of the emerging markets. The strategy often results in portfolios of small- and mid-cap stocks. David Semple, a veteran of emerging markets investing, is the primary portfolio manager, and he is supported by Angus Shillington, Patricia Gonzalez, Ola El-Shawarby, and Dominic Jacobson.

  • David A. Semple, Portfolio Manager

    • Industry Experience Since 1990
    • Joined VanEck in 1998
    • Bachelor of Law with Honors, University of Edinburgh (Scotland)
    • Portfolio Manager for the active Emerging Markets Equity Strategy
    • Oversees the Emerging Markets Equity team including company research, stock selection and portfolio construction
    • Joined VanEck in 1998
    • Prior to VanEck, served on the team sub-advising the VanEck Emerging Markets Strategy at Peregrine Asset Management (Hong Kong)
    • Previously, held regional strategy and sales positions at Peregrine Brokerage (Hong Kong)
    • Formerly a portfolio manager specializing in Asian equity markets at Murray Johnstone (Glasgow)
    • Member of the Association of Investment Management and Research (AIMR); member of the CFA Institute
    • Bachelor of Law with Honors, University of Edinburgh
  • Angus Shillington, Deputy Portfolio Manager

    • Industry Experience Since 1993
    • Joined VanEck in 2009
    • Former Head of International Equity for ABN AMRO
    • Deputy Portfolio Manager for the active Emerging Markets Equity Strategy
    • Joined VanEck in 2009
    • Prior to VanEck, headed International Equity at ABN AMRO
    • Previously, several senior roles in research, sales, trading and portfolio management with a focus on the Asian and European markets at BNP Paribas (NY/LA), UBS Securities (Hong Kong) and Hill Samuel/BLW (Edinburgh)
  • Patricia Gonzalez, Senior Analyst

    • Industry Experience Since 2008
    • Joined VanEck in 2014
    • MBA, Loyola University
    • BA, Economics, Universidad Catolica Andres Bello (Venezuela)
    • Senior Analyst for the active Emerging Markets Equity Strategy specializing in Latin America and Europe, Middle East and Africa (EMEA)
    • Joined VanEck in 2014
    • Prior to VanEck, Financial Analyst at Newgate Capital Management
    • MBA, Loyola University
    • BA, Economics, Universidad Catolica Andres Bello (Venezuela)
  • Ola El-Shawarby, CFA, Senior Analyst

    • Industry Experience Since 2005
    • Joined VanEck in 2017
    • MBA, Harvard Business School
    • BA, (summa cum laude), Business Administration (concentration in Finance), The American University in Cairo (Egypt)
    • BS, Political Science (minor in Economics), Cairo University (Egypt)
    • Senior Analyst for the active Emerging Markets Equity Strategy specializing in EMEA (Europe, Middle East and Africa)
    • Joined VanEck in 2017
    • Prior to VanEck, Director and Investment Analyst at Caravel Management LLC
    • Previously, Private Equity Summer Fellow at Kaust Investment Management Company
    • CFA charterholder; member of the CFA Society Egypt
    • MBA, Harvard Business School
    • BA, (summa cum laude), Business Administration (concentration in Finance), The American University in Cairo
    • BS, Political Science (minor in Economics), Cairo University
  • Dominic Jacobson, Analyst

    • Industry Experience Since 2015
    • Joined VanEck in 2018
    • MA, Chemistry, Imperial College London (England)
    • BS, Chemistry with Honours, University of Edinburgh (Scotland)
    • Analyst for the active Emerging Markets Equity Strategy specializing in technology and healthcare research
    • Joined VanEck in 2018
    • Prior to VanEck, Global Healthcare Analyst and North Asian Technology Analyst at Gavekal Capital
    • MA, Chemistry, Imperial College London
    • BS, Chemistry with Honours, University of Edinburgh